Cue Biopharma, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Cue Biopharma, Inc. (CUE) on March 28, 2022. The filing discloses the entry into a material definitive agreement regarding the relocation of the Company's corporate headquarters.
Key Financial Metrics
This filing does not report revenue, profit, cash flow, margins, or debt levels. The only financial data provided relates to the new lease agreement:
- Lease Term: April 15, 2022, to April 14, 2026 (4 years).
- Space: Approximately 13,000 square feet of office, R&D, and laboratory space at 40 Guest Street, Boston, MA.
- Rental Rates:
- Year 1: $200,700 per month
- Year 2: $208,728 per month
- Year 3: $217,077 per month
- Years 4-5: $225,760 per month
- Upfront Obligations: Prepayment of two months' rent and a security deposit.
Material Changes
The Company is relocating its headquarters to the new premises in April 2022. The filing incorporates the lease details into Item 2.03, noting the creation of a direct financial obligation. No other material changes to financial position or operations are disclosed in this specific report.
Outlook, Risks, and Management Commentary
The Company intends to move into the new facility in April 2022. The Licensor is obligated to provide specific services including gases, chemicals, equipment, IT support, security, and health and safety training. The Licensor retains the right to terminate the agreement for Cause. The filing does not provide forward-looking financial guidance or discuss specific risks beyond the standard lease terms.
Investor Verification Checklist
- Verify the total upfront cash outflow required for the two months' rent prepayment and security deposit.
- Confirm the exact delivery date of the premises to ensure the Term Commencement Date aligns with the April 2022 relocation target.
- Review the full text of the License Agreement (Exhibit 10.1) in the upcoming Form 10-Q for the quarter ending March 31, 2022, to understand termination clauses and service level details.
- Assess the impact of the escalating rental rates on the Company's future operating expenses.